TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies

Research output: Contribution to journalLetterpeer-review

14 Scopus citations
Original languageEnglish
Pages (from-to)e345-e348
JournalHaematologica
Volume104
Issue number8
DOIs
StatePublished - Jul 31 2019

Cite this